Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study
Addressing the Manufacturing Capacity Bottleneck in the Global Pharma Supply Chain When we speak of manufacturing capacity in the context of GLP-1s, we are really talking about two distinct but interconnected needs: API (Active Pharmaceutical Ingredient) production and drug product manufacturing, specifically fill-finish
The capsules are small, which is great, and the dosage does not complicate our daily schedule
Example tapering approach (for guidance only): If you are on a higher weekly dose, your clinician may reduce the dose step-by-step over several weeks, such as lowering the dose every 12 weeks (for example, from a higher dose to a mid dose, then to a lower dose) before stopping completely
Your doctor will likely check baseline kidney function and monitor it periodically, especially as you increase your semaglutide dose